Sentences with phrase «chemotherapy followed»

«This is the first molecular - targeted and first anti-angiogenesis therapy to demonstrate benefit in this population and, combined with chemotherapy followed by [Avastin] maintenance, should be considered as one standard option for women with this disease,» said lead researcher Dr. Robert A. Burger, director of the Women's Cancer Center at Fox Chase Cancer Center in Philadelphia.

As Dr. Maharaj explained, «One last option for Gale was high dose chemotherapy followed by an autologous bone marrow stem cell transplant.

This prospective, single - arm, phase II clinical trial was conducted to evaluate the safety, feasibility, and efficacy of induction chemotherapy followed by SABR in 34 patients who had biopsy - proven PDA.

Between April 1993 and March 2003, 1011 patients were randomized to four treatment arms, 252 patients received preoperative radiotherapy alone, 253 patients received preoperative radiotherapy — chemotherapy, 253 patients received preoperative radiotherapy followed by adjuvant chemotherapy, and 253 patients received preoperative radiotherapy and chemotherapy followed by adjuvant chemotherapy.

One month after the study treatment — which involves chemotherapy followed by intravenous infusion of JCAR017 — follow - up imaging showed complete remission of the brain lesion.

Prof Andrés Cervantes, Biomedical Research Institute, INCLIVA, University of Valencia, Spain, ESMO spokesperson, not involved in the study, commented: «This is a new understanding of how to treat a select group of patients that are wild - type for the KRAS, NRAS, BRAF and PIK3CA genes who can be treated with the same anti-EGFR antibody and a change in chemotherapy following progression.

Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic Oncology Group (GOG), a National Cancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of Medicine.

January 14, 2000 Protein predicts prognosis for breast cancer patients Low levels of E-cadherin, a protein that links cells together, appears to be the single most effective factor for predicting which patients with early breast cancer will need chemotherapy following surgery.

Low levels of a protein that helps link cells together appears to be the single most effective factor for predicting which patients with early breast cancer will need chemotherapy following surgery, report researchers from the University of Chicago Medical Center in the January 15, 2000 issue of Cancer Research.

Summary: Low levels of E-cadherin, a protein that links cells together, appears to be the single most effective factor for predicting which patients with early breast cancer will need chemotherapy following surgery.

Also, there were 2 dogs with adenocarcinoma which received chemotherapy following surgery.

Depending on the outcome of the surgery and the biopsy results, you may also be advised to consider chemotherapy following surgery.

• Adept at providing medical administration as per physician's advice • Proficient in providing chemotherapy sessions to patients • Track record of educating patients regarding cancer treatment and medication • Effective skills in maintaining patient charts and reminding them regarding chemotherapy follow up visit dates

Not exact matches

Surgery was followed by a year of chemotherapy.

She had been hospitalized a couple of times, received chemotherapy again, and those treatments were followed with the usual discomfort.

Yes, he couldn't possibly get to campus following chemotherapy and radiation for four months.

A brief course of chemotherapy will follow today's surgery.

That injection puts the «gas on» the immune system followed by a second injection of a drug being developed as a chemotherapy.

«Considering that PDPN is associated with poor prognosis in GBM, CAR T - cell therapy that targets this protein is promising for treatment of patients with relapsed or resistant tumors following first - line chemotherapy,» says Toshihiko Wakabayashi, a coauthor and the chair of Department of Neurosurgery Nagoya University School of Medicine.

The survival difference between the two groups was not statistically significant, but investigators said the results point to a possible benefit of GO treatment for some pediatric AML patients whose cancer remained following chemotherapy.

A blood cancer characterized by the rapid growth of abnormal white blood cells, AML is typically treated with chemotherapy, in some cases followed by a stem cell transplant.

Of the dogs stricken with osteosarcoma, 35 had the cancer in a leg which was subsequently amputated, followed by chemotherapy, which is the standard - of - care treatment; the dogs with elevated total cholesterol had a median survival time of 455 days, more than 200 days greater than the median survival time for dogs with normal cholesterol.

Among this group, chemotherapy is known to increase survival by up to 20 percent and is routinely recommended following surgery.

However, in the largest study of its kind so far, scientists from the German Cancer Research Center (DKFZ) in Heidelberg have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average population.

One patient, a 46 - year old woman, started the trial with stage 4 ovarian cancer — which generally has a very poor prognosis — following five prior courses of chemotherapy.

The benefit of chemotherapy, in addition to craniospinal radiation, was seen in adult patients with medulloblastoma (MB), including those with localized disease who received high - dose radiation treatment following surgery.

Dr. Jang, who is also an assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, performed the RPLND procedure on 29 patients from 2010 to 2016; 23 of these procedures were done following chemotherapy.

Intermittent dosing with rapamycin selectively breaks the cascade of inflammatory events that follow cellular senescence, a phenomena in which cells cease to divide in response to DNA damaging agents, including many chemotherapies.

For patients with glioblastoma multiforme, the vaccine did not seem to prevent the recurrence of cancer, so those patients were offered follow - up chemotherapy.

Instead, following exposure to chemotherapy, GSTO1 binds to a protein called the ryanodine receptor 1, or RYR1, that triggers the release of calcium, which causes a chain reaction that transforms ordinary breast cancer cells into cancer stem cells.

The interim analysis found a median progression - free survival rate of 9.7 months with consolidative radiation therapy followed by chemotherapy, versus 3.5 months for maintenance chemotherapy alone (p = 0.01; Hazard Ratio (HR) = 0.304, 95 % CI 0.113 - 0.815).

Prof Fortunato Ciardiello from Seconda Università degli Studi di Napoli, Italy, presented results from the CAPRI - Goim study on the efficacy of cetuximab plus FOLFOX chemotherapy as second - line treatment for patients with mCRC that progressed following FOLFIRI chemotherapy and cetuximab.

Further follow - up of the trial is ongoing to determine whether chemotherapy may also be effectively spared in patients who have a mid-range Recurrence Score between 11 and 25.»

Following surgery, chemotherapy and radiation, average survival is still only 15 months, pointing to a critical need for new treatments.

Patients with metastatic colorectal cancer (mCRC) that are mutation - free in the KRAS, NRAS, BRAF and PIK3CA genes showed significant benefit from continuing anti-epidermal growth factor receptor (EGFR) therapy beyond progression following first - line chemotherapy and an anti-EGFR monoclonal antibody, according to study results (1) presented today at the ESMO 17th World Congress on Gastrointestinal Cancer in Barcelona, Spain.

Following weeks of chemotherapy, she is now doing well.

Based on an analysis of existing evidence, published in an opinion article in the Nature Reviews Clinical Oncology journal on January 20, Dr. Narod argues that to achieve a cure, rather than simply delay progression or reoccurrence of the disease, women should be first treated with aggressive surgery to remove all clinically - detectable cancer cells, followed by targeted chemotherapy to the abdomen (intraperitoneal chemotherapy).

The study followed 826 participants in a clinical trial for a median of 6.5 years after they were treated with surgery and chemotherapy.

Patients in clinical remission — whose tumors have disappeared or are significantly reduced in size — are given a course of immune treatment after a six - month rest period following chemotherapy.

Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow - up show that 5 - FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)- radiotherapy for patients with cT3 - resectable T4 M0 rectal cancer does not improve survival or disease - free survival.

Prof. Jean - François Bosset of the CHRU de Besancon — Hopital Jean Minjoz in France and lead author of this study says, «When we looked at the results after five years median follow - up, we saw that chemotherapy, regardless of when it was administered, significantly improved local control.

The long term follow - up results suggest that new treatment strategies incorporating neoadjuvant chemotherapy are required, because adjuvant chemotherapy does not demonstrate any significant long term benefit on overall survival or disease - free survival.»

The team designed a different approach to study the therapy in myeloma, adding in an infusion of the patient's own stem cells along with their lymphodepleting chemotherapy (melphalan), followed by CTL019 infusion about two weeks later.

The 11 evaluable patients enrolled in the brain cancer safety trial received three infusions of vitamin C a week for 2 months followed by two infusions per week for 7 months while receiving standard care radiation and chemotherapy.

As next steps, Dr. Winocur will investigate these effects in cancer survivors who complain of chemo brain following chemotherapy.

A major clinical trial randomizing patients to either initial surgery followed by chemotherapy, or chemotherapy then surgery, revealed no significant difference in overall survival between the groups.

The multicentre trial included 153 patients with surgically - treatable malignant pleural mesothelioma, who were first treated with three chemotherapy cycles of cisplatin and pemetrexed, followed by surgical removal of affected lung tissue, with the goal of complete removal of the cancerous areas of lung.

The standard treatment of locally advanced cervical cancer is EBRT with concurrent chemotherapy, followed by brachytherapy.

Standard treatment is surgery, followed by radiation therapy and chemotherapy with temozolomide.

With a median follow - up of 36.7 months, the researchers found no survival benefit of chemoradiotherapy compared with chemotherapy, with median overall survival from the date of the first randomization of 15.2 months and 16.5 months, respectively.